Skip to main content

Table 3 Endothelial factors of different treatment (mean ± SD) (n = 8, each)

From: Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats

YXC (g/kg) Swimming (h) NO (pg/ml) ET (pg/ml) TXB2(pg/ml) 6-keto-PGF(pg/ml)
0 0 16.80 ± 3.99 69.54 ± 9.58 361.91 ± 56.38 57.08 ± 12.57
0 0.5 22.67 ± 4.28 60.32 ± 9.99 207.85 ± 66.03 84.86 ± 32.33
0 1 24.38 ± 4.47 66.04 ± 8.25 326.70 ± 155.64 78.76 ± 31.82
1 0 40.38 ± 7.61 73.21 ± 5.25 531.44 ± 126.99 65.84 ± 25.92
1 0.5 32.00 ± 9.56 60.21 ± 5.13 167.76 ± 86.16 63.27 ± 16.27
1 1 33.07 ± 8.07 65.16 ± 9.22 345.63 ± 139.01 69.27 ± 17.32
2 0 39.62 ± 6.61 53.55 ± 8.82 362.03 ± 76.92 105.91 ± 28.86
2 0.5 42.29 ± 12.83 62.75 ± 6.91 385.41 ± 157.32 85.35 ± 16.71
2 1 36.19 ± 6.51 64.14 ± 8.30 212.34 ± 90.98 45.26 ± 17.28
Two-way ANOVA   F P F P F P F P
YXC   37.361 0.000 3.642 0.330 0.778 0.466 1.544 0.224
Swimming   0.162 0.851 1.868 0.164 8.018 0.001 2.150 0.127
YXC × Swimming   3.142 0.020 4.418 0.004 5.479 0.001 6.322 0.001
  1. All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergism effect. Comparisons between each pair of factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 was considered statistically significant.
\